Author:
Czifra Árpád,Páll Alida,Kulcsár Julianna,Barta Kitti,Kertész Attila,Paragh György,Lőrincz István,Jenei Zoltán,Agarwal Anupam,Zarjou Abolfazl,Balla József,Szabó Zoltán
Abstract
Abstract
Background
Renal replacement therapy may have a favorable effect on diastolic left ventricular function, but it is not clear whether hemodiafiltration is superior to hemodialysis in this field. Nitric oxide (NO) and asymmetric dimethylarginine (ADMA) may play a role in the changes of intracardiac hemodynamics, but it is not clear whether the different renal replacement methods have disparate influence on the metabolism of these materials.
Methods
Thirty patients on renal replacement therapy were investigated. First, data was analyzed while patients received hemodiafiltration over a period of three months. Then, the same patients were evaluated during treatment with hemodialysis for at least another three months. Echocardiography was performed before and after renal replacement therapy.
Results
No significant difference was found in the volume removals between hemodialysis and hemodiafiltration. The left atrial diameter and transmitral flow velocities (E/A) decreased significantly only during hemodiafiltration. A positive correlation was observed between the left atrial diameter and E/Ea representing the left ventricular pressure load during hemodiafiltration. Significant correlations between NO and A and E/A were observed only in the case of hemodiafiltration.
Conclusion
Hemodiafiltration has a beneficial effect on echocardiographic markers representing left ventricular diastolic function. This could be attributed to the differences between the dynamics of volume removal and its distribution among liquid compartments.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. McCullough PA, Steigerwalt S, Tolia K, Chen SC, Li S, Norris KC, Whaley-Connell A, KEEP Investigators: Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP). Curr Diab Rep. 2011, 11 (1): 47-55. 10.1007/s11892-010-0162-y.
2. Arora N, Dellsperger KC: Heart failure and dialysis: new thoughts and trends. Adv Perit Dial. 2007, 23: 72-76.
3. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995, 47 (3): 884-890. 10.1038/ki.1995.132.
4. Douchet MP, Couppie P, Chantrel F, Kuntz C, Hannedouche T: Diastolic dysfunction in chronic renal failure patients under hemodialysis. Ann Cardiol Angeiol (Paris). 1996, 45 (10): 589-592.
5. Meyer C, Heiss C, Drexhage C, Kehmeier ES, Balzer J, Muhlfeld A, Merx MW, Lauer T, Kuhl H, Floege J, Kelm M, Rassaf T: Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function. J Am Coll Cardiol. 2010, 55 (5): 454-459. 10.1016/j.jacc.2009.07.068.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献